Schizophrenia :: Eli Lilly comments on recent court rulings regarding Zyprexa patents
Eli Lilly and Company (NYSE: LLY) responded to two recent court rulings by the Canadian Federal Court and the German Patent Court that could result in the entry of generic olanzapine (Zyprexa) into the Canadian and German markets.